These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1475991)

  • 1. [20 years pentoxifylline: a part of recent angiology history].
    Ernst E
    Wien Med Wochenschr; 1992; 142(19):433-7. PubMed ID: 1475991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The history of intermittent claudication due to arterial disease].
    Lacombe M
    Ann Chir; 2005; 130(6-7):440-4. PubMed ID: 16023462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical aspects on the development of angiology in Germany.
    Schoop W
    Int Angiol; 1986; 5(3):111-5. PubMed ID: 3549931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial.
    Thomson GJ; Thomson S; Todd AS; Vohra RK; Carr MH; Walker MG
    Int Angiol; 1990; 9(4):266-70. PubMed ID: 2099961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 10. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hemorheology in the pathophysiology and treatment of arterial occlusive disease.
    Rieger H
    Int Angiol; 1986; 5(3):161-7. PubMed ID: 3559317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method of measuring red cell deformability and the effects of pentoxifylline.
    Isogai Y; Mochizuki K; Ashikaga M
    Curr Med Res Opin; 1981; 7(6):352-8. PubMed ID: 7238085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses.
    Gillings DB
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S44-50. PubMed ID: 8699861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New aspects of the pharmacology of pentoxifylline].
    Lenoble Giovannangeli M
    J Mal Vasc; 1989; 14 Suppl A():35-41. PubMed ID: 2654314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conservative therapy of peripheral arterial occlusive diseases].
    Alexander K
    Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial reconstructions in the treatment of peripheral arterial occlusive disease. A historical retrospect].
    Kunlin J; Brunner U; Waibel P
    Vasa; 1986; 15(4):319-23. PubMed ID: 3541435
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of pentoxifylline administration on blood viscosity and leukocyte cytoskeletal function in patients with intermittent claudication.
    Rao KM; Simel DL; Cohen HJ; Crawford J; Currie MS
    J Lab Clin Med; 1990 Jun; 115(6):738-44. PubMed ID: 2366034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.